Researchers performed a meta-analysis of 29 studies on the use of triclosan-coated sutures to see if using those sutures, as opposed to non-triclosan-coated sutures, would reduce the risk of patients getting an SSI. Among those studies, the pooled relative risk ratio of acquiring an SSI was 0.65 in favor of using coated sutures.
In other words, the meta-analysis shows that using triclosan-coated sutures reduced the risk of SSI by 26 percent for surgical patients. The researchers noted the effect of the coated sutures “was particularly evident among those who underwent abdominal surgery.”
More articles on surgical site infections:
AORN’s new surgical attire recommended practices: 5 points to know
Patterns of secondary surgical complications: 5 findings
Preventing SSIs: The sterile processing connection
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
